NILHANZA

Welcome to the Brand page for “NILHANZA”, which is offered here for Pharmaceuticals, including those for use in oncology in humans; tyrosine kinase inhibitors for use in the treatment of cancer; drugs for use in treating chronic myelogenous leukemia;.

Its status is currently believed to be active. Its class is unavailable. “NILHANZA” is believed to be currently owned by “NANOCOPOEIA, LLC”.


Owner:
NANOCOPOEIA, LLC
Owner Details
Description:
Pharmaceuticals, including those for use in oncology in humans; Tyrosine kinase inhibitors for use in the treatment of cancer; Drugs for use in treating chronic myelogenous leukemia;
Categories: PHARMACEUTICALS